First up, host Meagan Cantwell speaks with Abigail Echo-Hawk, director of the Urban Indian Health Institute and chief research officer for the Seattle Indian Health Board. Echo-Hawk shares what inspired her journey in public health and explains the repercussions of excluding native people from health data.
This story was originally reported by Lizzie Wade, who profiled Echo-Hawk as part of Science’s “voices of the pandemic” series. Next, host Sarah Crespi interviews Danielle Murashige, a Ph.D. student at the University of Pennsylvania, about her Science paper that attempts to quantify how much fuel a healthy heart needs.
The US Surgeon General’s office has released a report emphasizing the importance of making hypertension control a national public health priority. Vice Admiral Jerome Adams, MD, MPH, the 20th US Surgeon General, discusses the report’s background and recommendations.
CENTERS FOR DISEASE CONTROL & PREVENTION (August 25, 2020) – A CDC study published today that looked at more than 80,000 U.S. adults hospitalized with flu over eight flu seasons (2010-11 through 2017-18) found that sudden, serious heart complications were common and occurred in one out of every eight patients (~12% of patients).
The study looked at a range of sudden heart complications called “acute cardiac events” that resulted in the following:
damage to the heart muscle,
inflammation of the heart muscle,
fluid or inflammation of the sac surrounding the heart, or
weakening of the pumping function of the heart.
The most common acute cardiac events reported in the study were acute heart failure and acute ischemic heart disease. Acute heart failure is the sudden inability of the heart to pump enough blood to meet the body’s demands, while acute ischemic heart disease is a term that describes heart problems caused by narrowed or blocked heart arteries.
The infographic urges patients not to ignore symptoms, especially if they have a heart condition, and reassures them that hospitals have safety measures to protect patients from infection with the novel coronavirus.
On the Mayo Clinic Radio program, Dr. Todd Miller, a Mayo Clinic cardiologist, explains how exercise affects the heart. This interview originally aired Feb. 22, 2020. Learn more about exercise and the heart: https://www.mayoclinic.org/healthy-li…
“This is an entirely new approach with no current treatments able to change scar in this way,” says Associate Professor James Chong who led the research. “By improving cardiac function and scar formation following heart attack, treatment with rhPDGF-AB led to an overall increase in survival rate in our study.”
The research centers on a protein therapy called recombinant human platelet-derived growth factor-AB (rhPDGF-AB), which had previously been shown to improve heart function in mice that had suffered a heart attack. In a new study aimed at bringing the treatment closer to human trials, a team set out to discover if it produced similar results in large animals, namely pigs.
The researchers from the Westmead Institute for Medical Research (WIMR) and the University of Sydney found that when pigs that had suffered a heart attack received an infusion of rhPDGF, it did indeed prompt the formation of new blood vessels in the heart and led to a reduction of potentially fatal heart arrhythmia.